ARCT Arcturus Therapeutics Holdings PE ratio, current and historical analysis
The current PE ratio of ARCT can't be determined, as the TTM EPS of -$3 is negative. The last PE ratio of Arcturus Therapeutics Holdings, recorded in September 2023, was 6.8.
ARCT PE ratio history
How has ARCT's PE ratio performed in the past
Today
N/A
Average
N/A
Median
N/A
Minimum
N/A
Maximum
N/A
Arcturus Therapeutics Holdings PE ratio by year
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | N/A | N/A | $16.97 | -$3 |
| 2023 | N/A | N/A | $31.53 | -$1.12 |
| 2022 | 48.46 | N/A | $16.96 | $0.35 |
| 2021 | N/A | N/A | $37.01 | -$7.74 |
| 2020 | N/A | N/A | $43.38 | -$3.55 |
| 2019 | N/A | N/A | $10.87 | -$2.15 |
| 2018 | N/A | N/A | $4.53 | -$2.16 |
| 2017 | N/A | N/A | $7.95 | -$3.53 |
| 2016 | N/A | N/A | $14.7 | -$0.77 |
| 2015 | N/A | N/A | $43.96 | -$0.94 |
| 2014 | N/A | N/A | $26.11 | -$16.8 |
| 2013 | N/A | N/A | $126 | -$7.28 |
| 2012 | N/A | N/A | N/A | -$1.4 |
| 2011 | N/A | N/A | N/A | -$3.5 |
Arcturus Therapeutics Holdings PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Dec 2024 | N/A | N/A | $16.97 | -$3 |
| Sep 2024 | N/A | N/A | $23.21 | -$2.34 |
| Jun 2024 | N/A | N/A | $24.35 | -$2.69 |
| Mar 2024 | N/A | N/A | $33.77 | -$4.03 |
| Dec 2023 | N/A | N/A | $31.53 | -$1.12 |
| Sep 2023 | 6.8 | -27.89% | $25.55 | $3.76 |
| Jun 2023 | 9.43 | 65.15% | $28.68 | $3.04 |
| Mar 2023 | 5.71 | -88.22% | $23.97 | $4.2 |
| Dec 2022 | 48.46 | N/A | $16.96 | $0.35 |
| Sep 2022 | N/A | N/A | $14.82 | -$5.56 |
| Jun 2022 | N/A | N/A | $15.74 | -$6.28 |
| Mar 2022 | N/A | N/A | $26.96 | -$7.53 |
| Dec 2021 | N/A | N/A | $37.01 | -$7.74 |
| Sep 2021 | N/A | N/A | $47.78 | -$7.63 |
| Jun 2021 | N/A | N/A | $33.84 | -$6.5 |
ARCT average PE ratio chart
What is the average PE ratio of ARCT for the past years
3-year avg
N/A
5-year avg
N/A
10-year avg
N/A
15-year avg
N/A
ARCT PE vs peers
What is ARCT's PE ratio compared to its peers
| Stock name | PE ratio | Market cap |
|---|---|---|
| NWBO Northwest Biotherapeutics Inc | N/A | $325.66M |
| ARCT Arcturus Therapeutics Holdings Inc | N/A | $394.59M |
Frequently asked questions
What is Arcturus Therapeutics Holdings's PE ratio?
The current price to earnings ratio of ARCT can't be calculated, as its EPS of -$3 is negative.
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.